@TotalHealthConf

#1 Provider in Free #Oncology Education | We produce tailored #CME content & conferences for oncologists & healthcare providers #MedEd #OncTwitter

 Virtual, In-Person & On-Demand
totalhealthconferencing.com/find-a-free-oncology-conference
Joined February 2017
  • Tweets4.6K
  • Following4.2K
  • Followers2.7K
1.8KMedia
Total Health™ retweeted
OncoNexus
@Onco_NexusMay 27
Which GI oncology abstracts could shape the biggest conversations coming out of ASCO 2026? On the latest episode of @TheGutOncLab, @GIMedOnc, @UGrewalMD, @TimothyJBrownMD break down key abstracts to watch, including potential plenary highlights, de escalation strategies, and data that could shape practice moving forward. Listen now on Onco Nexus: oncologynexus.com/podcast/gu…

ASCO 2026: GI Oncology Abstracts to Look Forward to - oncologynexus.com %

With the 2026 ASCO Annual Meeting just days away, Drs. Nicholas Hornstein, Timothy Brown, and Udhayvir Grewal sit down for a rapid-fire, “mouth-to-butt” preview of the most practice-altering abstra...

oncologynexus.com
3
5
415
Total Health™ retweeted
OncoNexus
@Onco_NexusMay 29
See you tonight at Frontiers Meet Frontlines! Final Registration: form.jotform.com/26112376258… Academic and community experts. Practice changing oncology data. Real discussion on what it means for patient care. @PBarataMD @GIMedOnc @mchayleh @YJanjigianMD @MikeLattanzi @AnaVManana @COlazagasti @Sarbaji85064063 @marklewismd @TotalHealthConf @_backtableONC
4
3
1,145
Replying to @TotalHealthConf
@TotalHealthConf
Ann Partridge MD, MPH@AnnPartridgeMDApr 20
Sign up and see Alaska!@TotalHealthConf @DFCI_BreastOnc
1
3
473
Total Health™ retweeted
Beverly Moy@BeverlyMoyApr 15
Join me and @Thalcin @adawaksmd @AnaVManana @SWentMD @MGBCI_BreastOnc @MassGenBrigham @DFCI_BreastOnc @UCSFCancer @DukeCancer & many more at Best of ASCO Boston! Registration is free.
Total Health™@TotalHealthConfApr 15
Total Health, along with our Program Chairs Dr. @BeverlyMoy and Dr. @Thalcin, invite you to the 2026 Best of ASCO® Boston conference taking place this summer! Save your spot today at: totalhealthoncology.com/upco… #OncologyEducation #FreeCME #TotalHealth
7
18
2,062
Total Health™ retweeted
OncoNexus
@Onco_NexusFeb 24
If activity is this compelling in wild-type patients, what comes next for Viktoria-1? Drs. Erica Mayer (@elmayermd) and Wassim Mchayleh discuss the VIKTORIA 1 data and explore how these results could shape expansion strategies and treatment positioning moving forward. Full Discussion --> oncologynexus.com/video/vikt… @TotalHealthConf #VIKTORIA #BreastCancer #HR #HER2
1
3
229
Total Health™ retweeted
Vumedi Oncology
@VuMediHemOncFeb 24
🩺 Postoperative complications remain a major concern in GI surgical oncology. @TotalHealthConf Natasha Goins, NP (@uthsc) reviews risk stratification, nutritional optimization, ERAS protocols, and management of liver, gastric, and pancreatic surgery complications. 🎥 Watch on #Vumedi: tinyurl.com/6bh5emh2 #SurgicalOncology #GIOncology #CancerCare

Common Postoperative Complications in GI Surgical Oncology: Risk Factors and Management

A video from Natasha Goins (as part of Total Health Oncology), posted on Feb 16, 2026.

vumedi.com
1
3
154
🎉 Congratulations to @DrChoueiri & colleagues on the @NEJM publication ! 👉🏼The study shows that cabozantinib plus nivolumab and ipilimumab significantly improves progression-free survival in patients with advanced renal-cell carcinoma. Amazing work! #kidneycancer @OncoAlert
Toni Choueiri, MD
@DrChoueiri10 May 2023
1/ Results from #COSMIC-313 are out @NEJM: 1st triplet combo (cabo/nivo/ipi) in #mRCC vs. a modern control (nivo/ipi). Initially presented as Plenary #ESMO22 session chaired by @CharlesSwanton @AndresC27622123 #ESMO22 Thread 🧵==> nejm.org/doi/full/10.1056/NE…
1
11
1
67
18,308
#CarboShortage: list of alternative regimens that group here at @WilmotCancer has put together as a gudiance. Appreciate any additional thoughts. 🙏🙏 @antonyruggeri & @shycollie for sharing your 📖. @OncoAlert #gism #gusm #OncTwitter #lcsm #bcsm @DrJFriedberg @oreganruth
4
36
3
81
16,579
Total Health™ retweeted
Yakup Ergün
@dr_yakupergun11 May 2023
#ESMOBreast23 EMERALD trial: Patient-reported outcomes ''There were no clinically meaningful differences across all time points in adverse events'' Presented by Dr. @JavierCortesMD @OncoAlert @myESMO
8
10
1,874
Total Health™ retweeted
Drew Moghanaki
@DrewMoghanaki10 May 2023
BREAKING: A new randomized trial demonstrates the benefit of SBRT for patients with EGFR+ stage IV NSCLC. It demonstrates both PFS and OS benefits (n=62). 🇨🇳 #radonc @EGFRResisters @jillfeldman4 thegreenjournal.com/article/…
9
84
6
228
46,264
Total Health™ retweeted
Oncology Brothers
@OncBrothers8 May 2023
w/ @CathyEngMD, we 🗣 the Rx algorithm for #ColonCancer and the pending #Fruquintinib approval. Full Int: - oncbrothers.com/colon-cathy-… - Also on the “Oncology Brothers” podcast 🎙️ @OncoAlert @GIcancerDoc #gism @HemOncFellows @VUMCHemOnc #crcsm #OncTwitter #MedTwitter #OncEd
15
1
64
55,324
Pre-print alert 🚨Excited to share our new preprint “The interplay between mutagenesis and extrachromosomal DNA shapes urothelial cancer evolution” 🧬🔬#bladdercancer bit.ly/3B3S2hi @OncoAlert
18
72
5
231
75,647
Total Health™ retweeted
Yakup Ergün
@dr_yakupergun9 May 2023
55 yo/m Adenocarcinoma in the 10th cm of the rectum. Two metastases in the KC, the largest of which is 3.8 cm (Potentially resectable). Preoperative systemic treatment was planned. What preoperative treatment would you recommend for this patient with RAS/RAF-wild and MSS? @OncBrothers @pashtoonkasi @IbrahimSahinMD1 @BijoyTelivala @coloncanada @UmutDisel
49%FOLFOX/CAPOX
51%FOLFOX + Anti-EGFR
215 votes • Final results
5
2
2
11
9,147
New publication alert! From the @Florez_Lab and the amazing Dr. @IvyRadOncMD at @DanaFarberNews Removing Gatekeeping to improve Hispanic/Latinx enrollment in clinical trials Link: redjournal.org/article/S0360… – at Boston, MA
1
23
3
83
21,667
Total Health™ retweeted
Arndt Vogel
@ArndtVogel9 May 2023
🔥Hot of the press: ALBI Analyses of Atezolizumab & Bevacizumab versus Sorafenib in #HCC @KargerPublisher doi.org/10.1159/000529996 🔎Post Hoc of IMbrave150 phs-III 👉ALBI prognostic & longer OS with AtezoBev in ALBI 1 🧐Observe liver function in HCC @EASLedu #livertwitter @myESMO
1
28
75
8,506
Finally out in @NEJM results from #POSITIVE trial showing that temporary interruption of #EndocrineTherapy to attempt #pregnancy is safe in #BreastCancer patients: this is wonderful news…super congrats @AnnPartridgeMD @etop_ibcsg et al! @OncoAlert #bcsm nejm.org/doi/full/10.1056/NE…
7
180
25
497
101,413
Total Health™ retweeted
Arndt Vogel
@ArndtVogel3 May 2023
🔥Lynch syndrome: a single hereditary cancer syndrome or multiple syndromes defined by different mismatch repair genes? @AGA_Gastro doi.org/10.1053/j.gastro.202… 🧐Interesting food for thoughts on tumor risk and carcinogenesis in #Coloncancer @myESMO @OncoAlert
15
156
4
338
41,382
Total Health™ retweeted
Asad Naveed@dr_asadnaveed25 Apr 2023
Can you distinguish between a T-test and Chi-square? Here are the commonest statistical tests everyone should know to analyse or interpret data: 📊👇 #MedTwitter
5
74
5
240
24,575
Total Health™ retweeted
Gonzalo Recondo@GRecondoMD25 Apr 2023
I am pleased to share our review on strategies for overcoming #osimertinib resistance in EGFR-mutant NSCLC @CCR_AACR with outstanding colleagues @JuanBlaquier @AndresFCardonaZ, @LauraMezquitaMD, @SandraOrtizCua & @BiagioMd #EGFR #LungCancer aacrjournals.org/clincancerr…
10
50
4
183
25,056
NEOTORCH study #ASCOPlenarySeries ➡️Phase III study w/ Pts with resectable stage II-III EGFR/ALK wild-type NSCLC ➡️Randomized to neoadj chemo (X3 cycles) ± Toripalimab followed by Adj chemo (x1)  ± Toripalimab vs placebo ➡️↑ MPR, ↑ pCR & ↑ EFS w/ Toripalimab @OncoAlert #LCSM
3
29
69
12,880
Load more